Status:
COMPLETED
Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects
Lead Sponsor:
UCB S.A. - Pharma Sector
Conditions:
Rhinitis, Allergic, Seasonal
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare the clinical efficacy of levocetirizine 5 mg and montelukast 10 mg on symptoms of seasonal allergic rhinitis occurring in subjects exposed to ragweed pollen in an environmental exposure uni...
Eligibility Criteria
Inclusion
- Have had seasonal allergic rhinitis due to Ragweed for the last 2 consecutive years
- Subjects who obtain a minimum sum score, considering Seasonal Allergic Rhinitis (SAR) related symptoms (mean value), as defined by the protocol
Exclusion
- Any clinically significant condition that might interfere with the treatment evaluation, both for efficacy and safety
- Have used forbidden concomitant medications as defined by the protocol
Key Trial Info
Start Date :
July 29 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
418 Patients enrolled
Trial Details
Trial ID
NCT00295022
Start Date
July 29 2006
End Date
October 1 2006
Last Update
September 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kingston, Ontario, Canada